Dr. Kevin Rodan, Chief Executive Officer of LataMed AI Corp. (OTC: LMED), is expected to receive a Certificate of Excellence from the Ministry of Health on July 10, 2026, in recognition of his contributions to healthcare innovation, technological development, clinical practice, and healthcare advancement. The recognition will be presented as part of Ministry of Health initiatives focused on acknowledging healthcare professionals whose work supports innovation, medical technology development, and high standards of patient care, according to information provided to the Company.
LataMed AI Corp. is a development-stage digital health and artificial intelligence technology company focused on telehealth infrastructure, healthcare analytics, and care coordination solutions for emerging markets. The Company believes that the recognition reflects Dr. Rodan’s continued commitment to advancing healthcare accessibility, digital health innovation, and the responsible application of technology within healthcare environments. Management also believes the recognition underscores the growing importance of healthcare technology, digital infrastructure, and innovation-focused leadership in supporting the modernization of healthcare systems throughout Latin America.
Dr. Rodan stated: “I am honored to be recognized in connection with healthcare innovation and excellence. Healthcare systems throughout Latin America continue to face significant accessibility, coordination, and infrastructure challenges, and I believe technology can play an important role in helping address those challenges. This recognition is meaningful not only personally, but also because it reflects the broader importance of innovation, collaboration, and patient-focused healthcare development.”
The Certificate of Excellence is expected to be presented during an upcoming Ministry of Health event dedicated to recognizing contributions to healthcare advancement, innovation, and excellence within the healthcare sector. The Company noted that the recognition relates to Dr. Rodan’s professional contributions and leadership within the healthcare sector and does not constitute a regulatory approval, endorsement, or certification of any specific product, service, technology, or commercial initiative of the Company.
This announcement highlights the growing emphasis on digital health innovation in Latin America, where healthcare systems face significant challenges in accessibility, coordination, and infrastructure. Dr. Rodan’s recognition by the Ministry of Health signals increasing governmental support for technology-driven solutions in healthcare. For LataMed AI, this acknowledgment could bolster its credibility as it continues to develop platforms for telehealth, healthcare analytics, and care coordination tailored to emerging markets. The Company’s strategy focuses on supporting healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, insurance accessibility, payment solutions, and data-driven operations, initially targeting Latin America.
Investors and industry observers may view this recognition as a positive indicator of the Company’s alignment with regional healthcare priorities. However, the Company’s forward-looking statements caution that actual results may differ materially due to risks such as financing availability, regulatory authorizations, operational execution, and market conditions. Additional information is available at https://latamed.ai and in the Company’s SEC filings at www.sec.gov.
